In this episode, James Campbell, MD, MS, FAAP, discusses the AAP’s updated recommendations for COVID-19 vaccines in infants, children and adolescents. David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, also speak with Scott Hadland, MD, MPH, MS, FAAP, about the use of buprenorphine for the treatment of opioid use disorder in young people.
Subscribe Now
Follow Pediatrics On Call
Guests
James Campbell, MD, MS, FAAP
Guest
Dr. James Campbell is a professor of pediatrics and the Interim Division Head of Pediatric Infectious Disease and Tropical Pediatrics at the University of Maryland School of Medicine. He is vice chair of the AAP Committee on Infectious Diseases.
Scott Hadland, MD, MPH, MS, FAAP
Guest
Dr. Scott Hadland is the Chief of Adolescent and Young Adult Medicine at Massachusetts General for Children and Harvard Medical School. Dr. Hadland’s clinical and research interests focus on adolescent and young adult substance use disorder prevention and treatment, and on improving care for youth and families affected by substance use. He is a member of the editorial board of Pediatrics and was the 2020 recipient of the Emerging Leader Award in Adolescent Health from the American Academy of Pediatrics.
Resources
Conflict of Interest Disclosure:
The interviewees have no conflicts of interest to disclose
Music Credits:
"Steadfast" by Blue Dot Sessions at www.sessions.blue
Theme music composed by Matthew Simonson at Foundsound.media
*The views expressed in this podcast are those of the guests and not necessarily those of the American Academy of Pediatrics.